Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.

American family physician·2024
Same author

The persistent challenge of diagnosing and treating vitamin B<sub>12</sub> deficiency.

BMJ (Clinical research ed.)·2024
Same author

Chronic Kidney Disease: Prevention, Diagnosis, and Treatment.

American family physician·2024
Same author

Pulmonary Nodules: Common Questions and Answers.

American family physician·2023
Same author

Scrotal Masses.

American family physician·2022
Same author

Adult Eye Conditions: Ophthalmic Emergencies.

FP essentials·2022

Related Experiment Video

Updated: Jul 10, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Ulcerative colitis: diagnosis and treatment.

Robert C Langan1, Patricia B Gotsch, Michael A Krafczyk

  • 1St. Luke's Family Medicine Residency, Bethlehem, Pennsylvania 18017, USA. langanr@slhn.org

American Family Physician
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Ulcerative colitis is a chronic inflammatory bowel disease. Diagnosis is endoscopic, with treatments ranging from 5-ASA compounds to surgery for severe cases, and regular colonoscopies are vital for cancer screening.

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Related Experiment Videos

Last Updated: Jul 10, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Area of Science:

  • Gastroenterology
  • Immunology
  • Colorectal Surgery

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with unknown etiology, characterized by recurrent symptoms and significant morbidity.
  • Extraintestinal manifestations affect up to 25% of UC patients.
  • Current diagnostic methods rely on endoscopy, with serological markers like perinuclear antineutrophilic cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) showing promise but not yet standard for routine use.

Purpose of the Study:

  • To provide a comprehensive overview of ulcerative colitis diagnosis, treatment, and management.
  • To highlight the importance of endoscopic diagnosis and risk stratification for colon cancer.
  • To discuss current and emerging therapeutic strategies for ulcerative colitis.

Main Methods:

  • Review of existing literature on ulcerative colitis etiology, diagnosis, and treatment modalities.
  • Analysis of current clinical guidelines for managing ulcerative colitis.
  • Discussion of the role of medical and surgical interventions, including novel therapies.

Main Results:

  • Diagnosis is primarily endoscopic, with specific timelines for colon cancer screening based on disease extent.
  • Treatment strategies are tailored to disease severity, utilizing 5-aminosalicylic acid (5-ASA) compounds, corticosteroids, and immunosuppressants like azathioprine or biologics such as infliximab.
  • Surgery is reserved for medically refractory cases or complications like hemorrhage, perforation, or cancer.

Conclusions:

  • Ulcerative colitis management requires a multi-faceted approach, balancing efficacy with the side effects of long-term therapies.
  • Early and appropriate medical intervention is crucial, with surgical options available for refractory disease.
  • Vigilant colon cancer surveillance is essential for patients with longstanding ulcerative colitis to mitigate cancer risk.